IONIS PHARMACEUTICALS DEF 14A 6-3-2016

Company

IONIS PHARMACEUTICALS INC

Filed

April 15, 2016

Period of Report

June 3, 2016

Accession Number

0001140361-16-061289

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →